Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chlorproguanil-dapsone for treating uncomplicated malaria.

H Bukirwa1, P Garner, J Critchley

  • 1Makerere University Malaria Project, Mulago Hospital Complex, Kampala, PO BOX 7423, Uganda. hbukirwa@liv.ac.uk

The Cochrane Database of Systematic Reviews
|October 21, 2004
PubMed
Summary

Chlorproguanil-dapsone shows promise for malaria treatment, but more research is needed. Current evidence suggests it may be less effective than sulfadoxine-pyrimethamine for uncomplicated falciparum malaria, with more adverse events.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Publisher Correction: Muscle abnormalities in Long COVID.

Nature communications·2025
Same author

Reply: Muscle abnormalities in Long COVID.

Nature communications·2025
Same author

The female medical workforce.

Anaesthesia·2021
Same author

Response to <i>IJTLD</i> article, "Having diabetes and being underweight in Asia: a potent risk factor for tuberculosis".

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2020
Same author

The effects of diabetes on tuberculosis treatment outcomes: an updated systematic review and meta-analysis.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2019
Same author

Diabetes and poor tuberculosis treatment outcomes: issues and implications in data interpretation and analysis.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2018

Area of Science:

  • Tropical Medicine
  • Pharmacology
  • Infectious Diseases

Background:

  • Malaria in Africa often exhibits resistance to chloroquine and sulfadoxine-pyrimethamine.
  • Chlorproguanil-dapsone presents a potential alternative antimalarial drug.

Purpose of the Study:

  • To compare the efficacy and safety of chlorproguanil-dapsone with other antimalarial drugs for treating uncomplicated falciparum malaria.

Main Methods:

  • Systematic review and meta-analysis of randomized and quasi-randomized controlled trials.
  • Searched multiple databases including Cochrane, MEDLINE, EMBASE, and LILACS up to May 2004.
  • Independent data extraction and quality assessment by two reviewers.

Main Results:

  • Single-dose chlorproguanil-dapsone (1.2 mg) showed fewer treatment failures than chloroquine but more than sulfadoxine-pyrimethamine.

Related Experiment Videos

  • Three-dose chlorproguanil-dapsone (2 mg) demonstrated fewer treatment failures by day 14 compared to sulfadoxine-pyrimethamine.
  • Chlorproguanil-dapsone was associated with increased adverse events leading to treatment discontinuation and red blood cell disorders.

    • Conclusions:

    • Insufficient data exist on the standard three-dose chlorproguanil-dapsone regimen (2 mg).
    • Further randomized controlled trials with day 28 follow-up, adverse event recording, and intention-to-treat analysis are necessary for policy decisions.